original clinical study Purpose: adult xanthogranulomatous disease of the orbit and ocular adnexa is a rare disease that can cause serious morbidity and mortality. ophthalmologists are commonly the first clinicians to come in contact with affected patients and an understanding of the clinical features is essential.
results

Clinical Features
demographic and clinical features are summarized in table 1. the most common subtype encountered was nBX, representing 4 of the 7 cases. there was 1 patient with each of the subtypes aoX, aaPoX, and Ecd. the mean age at diagnosis was 55.4 years (range, 24-75) and the majority of patients (71%) were male.
clinical presentation varied significantly both between and within subgroups . Four patients had bilateral orbital and adnexal disease, with the remaining 3 patients exhibiting unilateral disease. Four of the 7 patients had cutaneous xanthomatous lesions visible on the eyelids, representing the most common clinical finding. three patients demonstrated either bilateral or unilateral proptosis from the presence of orbital lesions. one of these patients experienced diplopia as a result of limitation of upgaze in the right eye. Palpable orbital masses were present in 3 patients, with 2 of these experiencing pain in relation to the masses. ulceration of the skin surface was present in conjunction with xanthomatous lesions in 2 of the 4 patients who had nBX but none of the patients with other subtypes. one of these patients initially presented with preseptal cellulitis as a result of the ulceration and the other developed a significant lower lid cicatricial ectropion with exposure keratopathy. two patients had mechanical upper eyelid ptosis as a result of the xanthogranulomatous lesions. only 1 patient experienced visual disturbance, which arose from mechanical compression of the globe. this led to the presence of choroidal folds, elevated intraocular pressure, and induced hypermetropia. a bilateral low-grade uveitis was present in 1 of the patients at initial presentation. associated systemic Conditions a number of patients in the cohort exhibited concurrent systemic findings along with the periocular xanthomatous lesions.
as expected, there were no systemic findings in the single case of aoX. the patient with aaPoX was a 57-year-old male who reported onset of asthma as an adult, which required longterm inhaled beta-agonist and corticosteroid therapy to control. He had also received treatment for allergic rhinitis, which started in adulthood, and bilateral endoscopic sinus surgery for chronic sinusitis. of the patients with nBX, 2 out of 4 had systemic involvement. Both patients had an underlying monoclonal gammopathy (paraproteinaemia). Patient 3 was a 50-year-old male who exhibited a monoclonal band of igg kappa paraprotein (85 g/l) on serum electrophoresis. upon further hematological investigation he was diagnosed with lymphoplasmacytic lymphoma. this had some features of multiple myeloma but did not meet the criteria for diagnosis. the patient had lytic lesions of the skull, femur, and vertebrae on skeletal survey. He also developed a unilateral recurrent laryngeal nerve palsy and bilateral sensorineural hearing loss from presumed vagus and cochlear nerve impingement from foci of lymphoma intracranially. Bence Jones proteins were absent. the other nBX patient was a 75-year-old female with a monoclonal gammopathy of uncertain significance. she had undergone repeat investigations for lymphoma and multiple myeloma, which were all negative. these included bone marrow biopsy, skeletal survey, and computed tomography (ct) scan of the chest, abdomen, and pelvis, which were all clear.
in addition to the periocular lesions, the patient with Ecd had widespread xanthogranulomata of the chest, arms, nasal mucosa, and trunk and also intra-abdominally. Multiple lesions of the long bones were also present. there was no renal, lung, or pericardial involvement.
radiological Features
Four of the patients underwent magnetic resonance imaging (Mri) scans, with the remainder having ct scans. all patients had orbital involvement demonstrating either wholly orbital disease or posterior extension of disease into the orbit. only 4 of the patients demonstrated subcutaneous lesions, including only 2 of the 4 patients with nBX. Extraocular muscles were involved in 4 cases. lacrimal gland enlargement was seen in 2 cases. levator muscle had extensive infiltration in 1 case of nBX. two cases of nBX showed an intraconal lesion location with 1 indenting the posterior aspect of the globe. the patient with Ecd demonstrated some bony destruction in relation to the lesions but bony change was not seen with any of the other cases. in all patients the lesions showed indistinct borders and an infiltrative appearance. on t1 Mri scans with fat suppression, the lesions were isointense or slightly hyperintense to muscle. Moderate enhancement was seen with gadolinium contrast. lesions were isointense to muscle on t2 scans. diffusion-weighted Mri was only done in a small number of cases and showed the lesions to be relatively hyperintense. computed tomography scans showed the lesions to be isointense to muscle.
histopathological Features a number of histological features were universally found in all subtypes of aoXgd. Foamy histiocytes were a prominent feature in all cases, as were touton multinucleated giant cells. a mixed inflammatory cell infiltrate was seen prominently in 5 of the 7 cases. the case of aoX demonstrated areas of calcification and fat necrosis. necrobiosis was present in 3 cases of nBX with 1 of these also showing areas of dense fibrosis. cholesterol clefts were also seen in 1 case of nBX. in the patient with Ecd significant fibrosis was seen, as was the presence of multiple microabscesses.
immunohistochemistry was performed in 5 out of 7 cases. cd68 was strongly positive in all of the patients tested. cd3 was tested for in 3 cases and was positive in each case. two patients were positive for cd20. the patient with Ecd was positive for cd163 and weakly positive for s100. three patients had testing for igg4 performed and 2 of these were positive. immunostains for the proteins cd4, cd8, cd30, cd15, and cd79a were positive in a single case each, although they were not tested in any other specimens. in addition, BraF mutations were tested for in the Ecd specimen but were negative. Histology and immunohistochemistry findings are summarized in table 2 and demonstrated in Figure 6 . treatment and outcomes a wide variety of treatment approaches was implemented among the cohort. the patient with aoX underwent surgical debulking of the lesion in her left superotemporal orbit. two years postoperatively she had disease recurrence in the left upper eyelid and nasal bridge. this was treated with further surgical debulking and a 6-week course of tapering oral prednisone with a maintenance dose of oral methotrexate 2.5 mg weekly for 12 months. she responded well to this treatment and has had no recurrence of disease in 8 years.
surgical debulking was also undertaken as first line treatment for the patient with aaPoX. the patient responded well to this until bilateral orbital recurrence 9 years later. at this point he underwent further surgical debulking and commenced a 6-week tapering course of oral prednisone plus azathioprine (aZt) at a maintenance dose of 150 mg/d. the patient had a good response to treatment and remains recurrence free after 2 years on the same maintenance dose of aZt. a number of different treatment modalities were undertaken for the nBX subgroup. the patient who developed lymphoplasmacytic lymphoma underwent 6 cycles of chemotherapy (cyclophosphamide, vincristine, doxorubicin, and prednisone) over 6 months. He subsequently achieved remission of the systemic malignancy and orbital component of disease. infiltration of superior rectus and levator muscle left some residual ptosis and upgaze deficits. He has had no recurrence in 2 years of follow-up.
the female patient with nBX who developed cicatricial ectropion and ulceration of the skin lesions was treated with 2 intralesional steroid injections (triamcinolone 40 mg/ml) 1 month apart. after this there was no visible or subjective improvement in the disease process. However, minimal progression was seen in the 8 months after the injections. Further systemic treatment is being considered but has not commenced at this stage. ongoing monitoring of her monoclonal gammopathy has not revealed any hematological malignancy to date after more than 2 years.
one of the nBX patients developed a large intraconal lesion with infiltrative appearance and poorly demarcated, feathery margins causing significant problems with diplopia. after biopsy confirmation of the disease, oral prednisone (1 mg/kg tapered over 6 months) was commenced with a plan to initiate rituximab therapy once funding approval was gained. the patient experienced dramatic improvement on the oral steroids alone within the first month such that rituximab therapy was withheld. Within 2 months the lesion shrunk to one third of its original size and at 6 months the lesion was almost completely resolved both clinically and radiologically (Fig. 7) . some vertical diplopia persisted even after the lesion had resolved but this was overcome with prism spectacle correction. the patient remained recurrence free at 12 months. the final nBX patient had surgical excision of a lesion, which was attached to the posterior surface of the globe. no adjunctive therapy was administered and he remained recurrence free after 18 months.
the patient with Ecd presented with periocular disease several years after the onset of his systemic disease. in the intervening period he had received 18 cycles of chemotherapy over a 13-month period, consisting of vinblastine and mercaptopurine. the chemotherapy had concluded more than 12 months before his presentation with mechanical ptosis secondary to a xanthogranulomatous lesion in the right upper eyelid. over that period he had also been on long-term oral prednisone, which had been tapered down from 25 mg to 10 mg. the patient reported little improvement after chemotherapy but at the time of writing was commencing interferon-alpha injections subcutaneously 3 times per week and was also under consideration for a peripheral stem cell transplant. Follow-up to date has been approximately 3 years after diagnosis. disCussion adult xanthogranulomatous disease of the orbit and ocular adnexa comprises a heterogeneous group of rare idiopathic inflammatory disorders that can be classified into 4 distinct syndromes: aoX, aaPoX, nBX, and Ecd. the underlying pathogenesis of each of these disorders is a localized or systemic proliferation of non-langerhans cell histiocytes but the precise mechanisms remain poorly understood.
all variants of adult orbital xanthogranulomatous disease involve inflammatory lesions within the orbit or ocular adnexal structures, which typically display a yellow coloration macroscopically. 1, 2 in addition, various systemic features may be present in adult xanthogranulomatous disease. adult-onset xanthogranuloma involves an isolated orbital inflammatory lesion. adult-onset asthma and periocular xanthogranuloma is a rarer entity that comprises the same orbital lesions found in aoX in association with late-onset asthma and occasionally reactive lymphadenopathy. 3 necrobiotic xanthogranuloma typically exhibits yellow periocular subcutaneous lesions, which often lead to ulceration and significant fibrotic change. involvement of deeper anterior orbital structures is often also present. serum protein abnormalities are almost universal, most commonly with a monoclonal igg paraproteinemia, present in more than 70% of cases and occasionally with cryoglobulinemia.
4-6 other lymphoproliferative disorders may occur, including B-cell malignancies and multiple myeloma. patient mortality. 11 our cohort displayed a large variety of clinical presentations, even within the same subclass. Within the nBX subgroup alone there were 4 very different presentations, namely, eyelid xanthomata, cicatricial ectropion, proptosis, and blurred vision from globe deformation. Previous studies have identified aoX, aaPoX, and nBX as occurring primarily in the preseptal and anterior orbital regions but in this cohort 2 of the nBX cases showed primarily posterior orbital disease and 1 other showed significant extension into the posterior orbit. no deaths from any of the subgroups had occurred but the Ecd patient only had a follow-up period of 3 years and is likely to experience more severe systemic involvement in the future.
in addition to the periocular lesions, a variety of other ocular manifestations have been reported with adult orbital xanthogranulomatous diseases. these include uveitis, episcleritis, scleritis, keratitis, conjunctivitis, keratoconjunctivitis sicca, glaucoma, and cataracts.
7 the frequency of these findings is uncertain but may be rare, given that in our cohort a single case of nBX had associated anterior uveitis but otherwise ocular involvement was not seen.
importantly, many patients with adult xanthogranulomatous disease present with periocular findings before detection of any underlying systemic abnormality. the ophthalmologist, therefore, has the important task of recognizing the condition and making appropriate referrals for systemic investigations. the most common associated conditions are hematological disorders, which are particularly common in patients with nBX. there may be a significant lag before the onset of hematological disease, with reports of multiple myeloma occurring up to 20 years after onset of 12 the mechanism of lesion formation in nBX has been purported to result from the abnormal paraprotein becoming complexed with lipid before being deposited in the skin, eliciting a giant cell-type granulomatous reaction.
8 some reports suggest that hematological abnormalities are ubiquitous in nBX but we found that only 2 out of 4 patients in our cohort exhibited these: 1 patient developed a lymphoplasmacytic lymphoma on the background of a paraproteinemia and the other had a monoclonal gammopathy of uncertain significance. other systemic involvement seen in our cohort consisted of the presence of adult-onset asthma and adult-onset allergic rhinitis in the patient with aaPoX along with widespread granulomata of the patient with Ecd.
Previous descriptions of the radiological features of aoXgd show that diffuse infiltrative lesions predominate and this was true for all of the cases in our cohort.
2,13 Extraocular muscle enlargement and lacrimal gland involvement are also common findings and they were present in 4 of 7 and 2 of 7 cases, respectively. it has been stipulated that bony destruction does not occur in the aoXgd disease process; however, in the case of Ecd within our cohort there was clearly an element of bony destruction seen within the paranasal sinuses in association with the xanthogranulomatous lesions 13 (Fig. 6 ). More recently fludeoxyglucose positron emission tomography (Fdd-PEt) has been identified as a potential useful adjunct in assessment and follow-up of aoXgd.
14 radiological findings are insufficient to make a diagnosis and tissue histology remains the diagnostic gold standard. characteristic histological features are shared by all subtypes of adult xanthogranulomatous disease. the findings in this cohort are in keeping with previous descriptions. aggregations of lipid-laden "foamy" histiocytes are universal. these can invade subcutaneous tissues and other periocular structures including orbicularis and lacrimal gland. lymphocytic infiltrates occur either as aggregates with typical germinal centers, or as more diffuse populations, and are commonly interspersed with proliferating fibroblasts.
1 in addition, touton multinucleated giant cells and plasma cells feature prominently. necrobiotic xanthogranuloma also displays areas of necrosis with surrounding aggregations of palisading epithelioid histiocytes. Proliferating fibroblasts are seen most prominently in Ecd lesions. there is a limited amount of data available regarding the immunohistochemical characteristics of adult xanthgranulomatous disease. Most lesions are strongly cd8 positive indicating the presence of suppressor or cytotoxic t cells. cd68, cd163, and factor Xiiia are also commonly positive.
1,15 no standardized approach exists to immunostaining of these lesions and therefore the immunohistochemistry findings in this cohort are hard to interpret. the most commonly used stain was cd68, which was positive in all cases tested.
the significance of igg4 positivity in xanthogranulomatous disease remains uncertain. Previous reports suggest that up to 50% of cases are positive for IgG4.
16 three quarters of these were not associated with systemic igg4-related disease. in this cohort 1 case each of aaPoX and nBX were positive for igg4, whereas another case of nBX was negative for igg4. the remaining 4 cases were not tested. controversy still exists over whether igg4 is involved in the pathological inflammatory process or whether it represents a reactive change within inflammatory tissues.
the heterogeneity of treatment regimens reflects the rarity of this disease and the lack of a standardized management approach. Moreover, the success of these treatments has been variable. conservative management is an option if the patient is asymptomatic but issues such as proptosis, diplopia, orbital pain, mechanical ptosis, and cosmetically disfiguring skin lesions necessitate treatment. a common therapeutic starting point is oral corticosteroids due to their easy availability and relatively low cost. oral prednisone has been shown to induce rapid improvement in lesion size and symptoms in some cases.
14 We experienced this directly in our cohort with a case of nBX (patient 6) that exhibited significant shrinkage of a large irregular intraconal lesion within the period of 1 month. Within 3 months almost complete resolution had occurred and previous plans to commence rituximab treatment were abandoned.
Methotrexate has shown some promise in patients who were refractory to other treatments. 17 another patient from this cohort responded well to a combination of oral steroid and methotrexate for a recurrence of aaPoX and has remained recurrence free on a small maintenance dose of methotrexate only. a combination of azathioprine and prednisone has also been successfully used to stop progression and reverse the disease in some instances.
18 intralesional steroid and systemic rituximab have both been shown to induce remission of orbital disease in some cases. 19, 20 More recently, thalidomide and lenalidomide have been used to successfully treat nBX.
21 radiotherapy has produced mixed results: although 1 case report suggested remission of orbital disease, another study found radiotherapy was of no benefit in any of 4 cases who had not responded to systemic corticosteroids, with 3 out of 4 actually showing an exacerbation of symptoms. 22, 23 BraF mutations have been identified as a possible etiological factor in Ecd but not other xanthgraulomatous diseases. treatment with a BraF inhibitor (vemurafenib) has shown promising results to date.
24,25 the Ecd patient in our cohort was negative for any BraF mutations.
our experience showed that surgical debulking of lesions alone led to a recurrence rate of 50%. These recurrences were subsequently controlled with multiple-agent chemotherapy. the 1 patient with nBX who had intralesional steroid showed no improvement after 2 injections. the rapid response patient 6 had to prednisone suggests that this should be a first-line consideration. a combination of surgical debulking where necessary plus multiagent chemotherapy including oral prednisone is probably a reasonable initial approach to treatment.
in conclusion, adult orbital and adnexal xanthogranulomatous disease is a rare but potentially serious group of diseases due to the associated systemic manifestations. diagnosis is made by a combination of history, examination, and characteristic histological findings. there is no standardization of treatment due to the rarity of the disease but many options exist. due to the periocular signs and symptoms, ophthalmologists are frequently the first medical practitioners to whom these patients present. recognition, timely investigation, and referral to a physician are essential.
